<DOC>
	<DOCNO>NCT00003197</DOCNO>
	<brief_summary>RATIONALE : Green tea extract contain ingredient may slow growth certain cancer , well prevent development new cancer . PURPOSE : Phase I trial study effectiveness green tea extract treat patient advance solid tumor refractory standard therapy .</brief_summary>
	<brief_title>Green Tea Extract Treating Patients With Advanced Solid Tumors</brief_title>
	<detailed_description>OBJECTIVES : I . Determine maximum tolerate dose green tea extract administer daily adult solid tumor . II . Determine safety chronic daily administration green tea extract patient . III . Investigate clinical pharmacology green tea extract study . IV . Document observe antitumor activity treatment . OUTLINE : This dose escalation study green tea extract . Patients receive green tea extract mouth daily meal 4 week . One patient enter dose level . If grade II toxicity experience , 2 patient enter dose level . One patient must complete 4 week therapy 2 others must complete 2 week therapy great grade I toxicity dose escalation proceeds . If least 2 patient experience dose limit toxicity dose level , immediately precede dose level consider maximum tolerate dose ( MTD ) . At least 6 patient study MTD . Patients may continue therapy 6 month absence toxicity disease progression . Patients follow every 4 week duration treatment least one month complete treatment . PROJECTED ACCRUAL : Approximately 30 patient accrue study .</detailed_description>
	<criteria>DISEASE CHARACTERISTICS : Pathologically prove incurable advanced solid tumor refractory standard therapy standard therapy exist No known brain metastasis PATIENT CHARACTERISTICS : Age : 18 Performance status : Zubrod 02 OR Karnofsky 70100 % Life expectancy : Not specify Hematopoietic : WBC least 4,000/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 1.5 mg/dL AST le 1.25 time normal Renal : Creatinine great 1.5 mg/dL Cardiovascular : No significant cardiac disease Other : No significant metabolic disorder No significant infection Not pregnant nursing Effective contraception must use fertile woman PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : At least 3 week ( 6 week nitrosourea ) since prior chemotherapy recover Endocrine therapy : Not specify Radiotherapy : At least 3 week since prior radiotherapy recover Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>